“High” TNFAIP6 expression is a poor prognosis marker when compared to “low and medium” TNFAIP6 expression levels in the TCGA-BLCA (Figure 6J) and BC2001 (Figure 6K) cohorts. This evidence concerns the gene TNFAIP6 and bladder transitional cell carcinoma.